Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IGC Pharma (IGC) Interest Expenses (2016 - 2017)

IGC Pharma (IGC) has disclosed Interest Expenses for 8 consecutive years, with $60527.0 as the latest value for Q4 2017.

  • Quarterly Interest Expenses rose 30.26% to $60527.0 in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $60527.0 through Sep 2018, down 72.35% year-over-year, with the annual reading at $223464.0 for FY2017, 4.46% up from the prior year.
  • Interest Expenses for Q4 2017 was $60527.0 at IGC Pharma, up from $40832.0 in the prior quarter.
  • The five-year high for Interest Expenses was $390486.0 in Q1 2013, with the low at $33928.0 in Q1 2016.
  • Average Interest Expenses over 5 years is $77837.0, with a median of $60848.5 recorded in 2014.
  • The sharpest move saw Interest Expenses soared 1880.46% in 2013, then plummeted 85.13% in 2014.
  • Over 5 years, Interest Expenses stood at $52502.0 in 2013, then increased by 18.01% to $61957.0 in 2014, then decreased by 17.68% to $51000.0 in 2015, then fell by 8.89% to $46465.0 in 2016, then surged by 30.26% to $60527.0 in 2017.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $60527.0, $40832.0, and $44546.0 for Q4 2017, Q3 2017, and Q2 2017 respectively.